僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Lusvertikimab （OSE-127） is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia （BCP-ALL） research